Pain Therapeutics, Inc., a biopharmaceutical company, has received a $5 million milestone payment from King Pharmaceuticals, Inc., its exclusive commercial partner for abuse-resistant prescription pain medications.
Pain Therapeutics receives milestone payment from King Pharmaceuticals